Trial intelligence / Profile preview

Esterified Estrogens and Methyltestosterone for Vasomotor Symptoms

NCT00160342Phase 2Completed

Sponsor
Solvay
Start
Jun 2005
Primary completion
Sep 2007
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
3
01

Overview

A Phase 2 trial of esterified estrogens, methyltestosterone in vasomotor symptoms of menopause (VMS), sponsored by Solvay. Started Jun 2005; status: completed.

02

Drugs

esterified estrogensmethyltestosterone
03

Conditions

vasomotor symptoms of menopause (VMS)

Beyond the preview

Go deeper on NCT00160342.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00160342.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call